Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients with Nominally Controlled LDL-Cholesterol | JACC Podcast | lystn | Audio Stories, Podcasts, Originals

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients with Nominally Controlled LDL-Cholesterol

Commentary by Dr. Valentin Fuster

2356 232

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients with Nominally Controlled LDL-Cholesterol3 years ago

11:33

Suggested Podcasts

Pop Shop Podcast

CREOGs Over Coffee

The Lizzie McFire Podcast

Straight Chilling: Horror Movie Review

Radical Candor

Teen Mom Trash Talk

POS

Learn Cantonese | CantoneseClass101.com

Satsang with Sitar

Inside Geneva

Download the app

Get it on Google Play Available on the App Store

PRIVACY POLICY | TERMS AND CONDITIONS

lystn.fm © 2024.
ALL RIGHTS RESERVED. CONTENT IS COPYRIGHT OF RESPECTIVE CONTENT OWNERS. | NX Digital FZ LLC & Tellyfonic Digital Media